Cutaneous Paraneoplastic Manifestations of Hematological Malignancies
DOI:
https://doi.org/10.24950/rspmi.745Keywords:
Hematologic Neoplasms, Paraneoplastic Syndromes, Skin DiseasesAbstract
The skin, as the largest organ of the human body, can have
a key role in the early diagnosis of systemic diseases. Cutaneous
manifestations can be the initial symptom of certain
malignant hematological diseases (Hodgkin lymphoma,
chronic lymphocytic leukemia, acute myeloid leukemia).
These can be classified as specific when caused by direct
invasion of malignant cells in the skin or by loco-regional expansion
of the tumoral disease or unspecific when caused
by the altered regulation of the immune system typical of
oncologic patients (characterized by absence of neoplastic
cells in the skin). The unspecific injuries are more frequent,
have polymorphous appearance and may precede, follow
or have a parallel course with the underlying malignancy. In
this article, the most frequent cutaneous diseases associated
with hematological malignancies are reviewed, namely
neutrophilic dermatoses (Sweet syndrome and pyoderma
gangrenosum), connective tissue diseases (dermatomyositis),
pruritus of unknown origin and vesiculobullous disorders
(pemphigus vulgaris and paraneoplastic pemphigus).
Although less common, other diseases are also associated
with malignancy such as amyloidosis, reactive erythemas,
vascular dermatoses (livedo reticularis, erythromelalgia and
vasculitis) and other disorders (acanthosis nigricans, sign of
Leser-Trélat and acquired ichthyosis). The main purpose of
this review is to highlight the relevance of cutaneous manifestations
that can be the first symptom of hematological malignancies
and lead to differential diagnosis.
Downloads
References
Carlesimo M, Narcisi A, Rossi A, Saredi I, Orsini D, Pelliccia S, et al. Cutaneous manifestations of systemic non-Hodgkin lymphomas (NHL): study and review of the literature. J Eur Acad Dermatol Venereol. 2014; 28:133-41.
Kurzrock R, Cohen PR. Mucocutaneous paraneoplastic manifestations of hematologic malignancies. Am J Med. 1995; 99:207-16.
Lear JT, Atherton MT, Byrne JP. Neutrophilic dermatoses: pyoderma gangrenosum and Sweet’s syndrome. Postgrad Med J. 1997; 73:65-8.
Cohen PR, Kurzrock R. Sweet’s syndrome: a review of current treatment options. Am J Clin Dermatol. 2002; 3:117-31.
Cohen PR. Sweet’s syndrome – a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007; 2:34.
Luthra HS. Chapter 22: Relapsing Polychondritis. In: Klippel JH, Stone JH, Crofford LJ, White PH, editors. Primer on the rheumatic diseases. Atlanta: Springer,Arthritis foundation; 2007. p.451-3.
Myers B, Gould J, Dolan G. Relapsing polychondritis and myelodysplasia: a report of two cases and review of the current literature. Clin Lab Haematol. 2000; 22: 45-7.
András C, Ponyi A, Constantin T, Csiki Z, Szekanecz, Szodoray P, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol. 2008; 35:438-44
Marie I, Guillevin L, Menard J-F, Hatron PY, Cherin P, Amoura Z, et al. Hematological malignancy associated with polymyositis and dermatomyositis. Autoimmun Rev. 2012; 11:615-20.
Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003; 362:971-82.
Bolognia JL, Schaffer JV, Duncan KO, Ko CJ. Dermatology Essentials. Philadelphia: Elsevier Saunders; 2014.
Yosipovitch G. Pruritus - an update. Curr Probl Dermatol. 2003; 15:135-64.
Yosipovitch G. Chronic pruritus: a paraneoplastic sign. Dermatol Ther. 2010; 23: 590-6.
Krajnik M, Zylicz Z. Understanding pruritus in systemic disease. J Pain Symptom Manage. 2001; 21: 151-68.
Nguyen VT, Ndoye A, Bassler KD, Shultz LD, Shields MC, Ruben BS, et al. Classification, clinical manifestations and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome. Arch Dermatol. 2001; 137: 193-206.
Chaves MY, Pérez PU. Cutaneous manifestations of systemic malignancies: Part 2. Actas Dermosifiliogr. 2013; 104:543-53.
Anhalt GJ, Kim S, Stanley JR, Korman NJ, Jabs DA, Kory M, et al. Paraneoplastic pemphigus – an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990; 323: 1729-35.
Steele HA, George BJ. Mucocutaneous paraneoplastic syndromes associated with hematologic malignancies. Oncology. 2011; 11: 1076-83.
Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest. 1999; 103: 461-8.
Medscape.com [homepage in the Internet] Amyloidosis; 2014 [assessed 23 February 2016]. Available from: http://emedicine.medscape.com/article/335414-overview#a1
Tyring SK. Reactive erythemas: erythema annulare centrifugum and eythema gyratum repens. Clin Dermatol. 1993; 11:135-9.
Jorizzo JL. Classification of urticaria and reactive inflammatory vascular dermatoses. Dermatol Clin. 1985; 3:3-12.
Norton JV, Zager E, Grady JF. Erythromelalgia: Diagnosis and classification. J Foot Ankle Surg. 1999; 38:238-41.
Jenette CJ, Milling DM, Falk RJ. Vasculitis affecting the skin. Arch Dermatol. 1994; 130:899-906.
Sánchez NB, Canedo IF, García-Patos PE, Pérez PU, Pascual AM. Paraneoplastic vasculitis associated with multiple myeloma. J Eur Acad Dermatol Venereol. 2004; 18:731-5.
Sinha S, Schwartz RA. Juvenile acanthosis nigricans. J Am Acad Dermatol. 2007; 57:502-8.
Safal B, Grant JM, Good RA. Cutaneous manifestation of internal malignancies (II): sign of Leser-Trélat. Int J Dermatol. 1978; 17: 494-5.
Patel N, Spencer LA, English JC, Zirwas MJ. Acquired ichthyosis. J Am Acad Dermatol. 2006; 55:647-56.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Medicina Interna
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna